Competitive problems in the drug industry: hearings before Subcommittee on Monopoly and Anticompetitive Activities of the Select Committee on Small Business, United States Senate, Ninety-first Congress, first session ... |
From inside the book
Results 1-5 of 92
Page 11638
... received by the Department of HEW in re- sponse to the publication of the Maximum Allowable Cost regulations in the Federal Register . While such comments are generally expected to reflect the real voice of the people , an analysis of ...
... received by the Department of HEW in re- sponse to the publication of the Maximum Allowable Cost regulations in the Federal Register . While such comments are generally expected to reflect the real voice of the people , an analysis of ...
Page 11639
... received stating the positions of various organi- zations . The positions of the organizations were quite predictable : State and local medical and pharmaceutical organizations were uniformly opposed , while consumer organizations were ...
... received stating the positions of various organi- zations . The positions of the organizations were quite predictable : State and local medical and pharmaceutical organizations were uniformly opposed , while consumer organizations were ...
Page 11650
... received from consumers who would stand to benefit from the increased prescribing of lower cost alterna- tives . Interestingly , the majority of favorable consumer letters we did receive came from Dayton , Ohio , an area where the ...
... received from consumers who would stand to benefit from the increased prescribing of lower cost alterna- tives . Interestingly , the majority of favorable consumer letters we did receive came from Dayton , Ohio , an area where the ...
Page 11651
... plan public some months ago , and it is strongly reiter- ated in a number of the comments we received among the 2,300 . I think they misunderstand what we are trying to do COMPETITIVE PROBLEMS IN THE DRUG INDUSTRY 11651.
... plan public some months ago , and it is strongly reiter- ated in a number of the comments we received among the 2,300 . I think they misunderstand what we are trying to do COMPETITIVE PROBLEMS IN THE DRUG INDUSTRY 11651.
Page 11653
... receiving these billions of dollars . So whenever you have a program of this kind , Mr. Chairman , this kind of proposal to reduce the cost inevitably has to accompany it , and as the temporary trustees of the Government's ...
... receiving these billions of dollars . So whenever you have a program of this kind , Mr. Chairman , this kind of proposal to reduce the cost inevitably has to accompany it , and as the temporary trustees of the Government's ...
Other editions - View all
Common terms and phrases
actual acquisition cost agencies antisubstitution laws APhA average wholesale price bioavailability bioequivalence brand name central CHAIRMAN competitive Defense develop Digoxin dispensing Drug Administration drug product Drug Research Board effective erythromycin established Food and Drug formulary Gaylord Nelson GORDON Government Government-wide hospital implementation inspection Interagency Labs local purchases MAC price MAC program MAC regulations Manufacturing Practices Maximum Allowable Cost Medicaid MEDICAL AND NONPERISHABLE medical items Medicare meeting ment MICHELOTTI patient percent Pharmaceutical pharmacists pharmacy physician PITTMAN prednisone prescribed present problems procurement professional proposed regulations purchasing quality assurance quality assurance program recommendations reimbursement resolution responsibility savings SCHMIDT Secretary WEINBERGER selection Small Business Sorett specific standards statement STETLER subcommittee substitution laws Supply Management Committee Tablets task group therapeutic equivalence tion TRYGSTAD WHITWORTH
Popular passages
Page 12087 - Since many agencies, including the Food and Drug Administration in the Department of Health, Education and Welfare, in which the appellant was employed, have nothing to do with national security, the Act of 1950 has nothing to do with them. The authorization to bring "other...
Page 12159 - Register, to be In the public interest in connection with the performance of duties imposed on that agency by law.
Page 11700 - I AM PLEASED TO BE HERE TODAY AND TO HAVE THE OPPORTUNITY TO ASK QUESTIONS OF SECRETARY JACKSON.
Page 12328 - Engineering before the Subcommittee on Health of the Senate Committee on Labor and Public Welfare, 94th Cong., 1st Sess.
Page 12055 - The hearing need not be conducted according to technical rules relating to evidence and witnesses. Any relevant evidence shall be admitted if it is the sort of evidence on which responsible persons are accustomed to rely in the conduct of serious affairs, regardless of the existence of any common law or statutory rule which might make improper the admission of such evidence over objection in civil actions.
Page 11663 - OF THE SELECT COMMITTEE ON SMALL BUSINESS, Washington, DC The subcommittee met, pursuant to notice, at 10 am, in room 2221.
Page 11925 - Action is pleased to have the opportunity to present its views on the $12.7 billion supplemental appropriation for America's efforts in Vietnam.
Page 11732 - STATEMENT OF ALEXANDER M. SCHMIDT, MD, COMMISSIONER, FOOD AND DRUG ADMINISTRATION; ACCOMPANIED BY J. RICHARD GROUT, MD, DIRECTOR, BUREAU OF DRUGS; PETER BARTON »HUTT, ASSISTANT GENERAL COUNSEL; LLOYD B. TEPPER, MD, ASSOCIATE COMMISSIONER FOR SCIENCE; BARRETT SCOVILLE, MD, ACTING DIRECTOR OF THE DIVISION OF BUREAU OF NEUROt PHARMACOLOGICAL PROJECTS; AND ROBERT WETHERELL, DIRECTOR, OFFICE OF LEGISLATIVE SERVICES Dr.
Page 12055 - substantial evidence" means : Evidence consisting of adequate and well controlled investigations, including clinical investigations by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling...
Page 12054 - The means employed shall be such as to allow, to the extent practicable, eligible persons to secure health care in the same manner employed by the public generally, and without discrimination or segregation based purely on their economic disability.